Evidence map›Paper›PMID 37805626›Full record

ArticleBone marrow transplantation2024

Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry.

Risa Koresawa-Shimizu, Ritsuro Suzuki, Yasufumi Uehara, Nobuhiro Hiramoto, Masashi Sawa, Takahiro Fukuda, Keisuke Kataoka, Yoshinobu Kanda, Tatsuo Oyake, Yasushi Kubota and 6 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 1 country.

Risa Koresawa-ShimizuDepartment of Hematology, Kawasaki Medical School, Kurashiki, Japan.ORCID 0009-0009-2570-0007
Ritsuro SuzukiDepartment of Oncology/Hematology, Shimane University Hospital, Izumo, Japan.ORCID 0000-0002-5974-7614
Yasufumi UeharaDepartment of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kokura, Japan.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Masashi SawaDepartment of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Takahiro FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Keisuke KataokaDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Yoshinobu KandaDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0000-0002-4866-9307
Tatsuo OyakeDivision of Hematology and Oncology, Iwate Medical University, Iwate, Japan.
Yasushi KubotaDepartment of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.ORCID 0000-0001-7785-1362
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan.ORCID 0000-0001-5952-5926
Shingo YanoClinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.ORCID 0000-0002-5895-5382
Hikaru KobayashiDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
Junji TanakaDepartment of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.ORCID 0000-0003-4404-2870
Eisei KondoDepartment of Hematology, Kawasaki Medical School, Kurashiki, Japan. eisei-k@med.kawasaki-m.ac.jp.ORCID 0000-0003-0995-9405
Kawasaki Medical School · JPAichi Medical University · JPAnjo Kosei Hospital · JPIwate Medical University · JPJichi Medical University · JPJikei University School of Medicine · JPKeio University · JPKitakyushu Municipal Medical Center · JPKobe City Medical Center General Hospital · JPNagano Red Cross Hospital · JPShimane University Hospital · JPSocial Insurance Saitama Chuo Hospital · JPTokyo Women's Medical University · JPToranomon Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLymphoma, Large B-Cell, DiffuseLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsHumansJapanTransplantation, Autologous

Identifiers

PMID37805626
OpenAlexW4387429768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.